HEART VALVES SANTA ANA FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 995 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Pericardial Effusion (3271); Heart Block (4444)
|
Event Date 03/29/2021 |
Event Type
Injury
|
Event Description
|
Medtronic received information via literature regarding the outcomes for patients implanted with a freestyle aortic root to treat severe necrotizing endocarditis.All data were collected from a single center between january 2000 and december 2018.The study population included 45 patients (predominantly male, mean age 70.9 years) all with active infective endocarditis.All patients were implanted with a medtronic freestyle aortic root bioprosthesis (unique device identifier numbers not provided).Among all patients, 7 deaths occurred within 30 days of implant.One patient presented with hemorrhagic pericardial effusion due to fistula which required complex patch repair and neoannulus reconstruction.After weaning from cardiopulmonary bypass (cpb) the patient developed severe hemorrhage and died peri-operatively.Other early deaths were caused by septic multiorgan failure, mesenteric ischemia, and low cardiac output-syndrome.The physician/authors noted severe sepsis as a predictor of 30-day mortality.During a follow-up with a mean of 3.6 years there were 19 deaths.Patients with concomitant surgeries were a predictor for late mortality.No further details were provided on the deaths.Based on the available information medtronic product had no causal or contributory relationship with the deaths.Among all patients, adverse events included: complete heart block with implant of a permanent pacemaker, bleeding requiring intervention, hemorrhagic pericardial effusion, and staphylococcal infection.Based on the available information medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
|
|
Manufacturer Narrative
|
Citation: hansen et al.The freestyle valve in severe necrotizing aortic root endocarditis: comorbidity upon outcome.Thorac cardiovasc surg.2021 mar 29.Doi: 10.1055/s-0040-1722652.Earliest date of publish used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the physician/author stated: 1) that medtronic product did not cause or contribute to the observed adverse events, 2) unique device identifiers were not available, 3) no products were available for return, and 4) the mean weight of the study population was 77.7 kg.
|
|
Search Alerts/Recalls
|
|
|